What does MedMira Inc. do?

MedMira Inc. (MIR.V) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is MIR.V's market cap?

MedMira Inc. (MIR.V) has a market capitalization of approximately $49.1 million, as of August 27, 2026, based on the most recent share price and shares outstanding.

Does MIR.V pay a dividend?

No — MedMira Inc. (MIR.V) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

MedMira Inc. (MIR.V) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

MIR.V

MedMira Inc.

TSXV·Biotechnology · Healthcare

C$0.07C$0.00+0.00%

Market capC$49.12M·Market closed·Aug 27 2:35 PM UTC

Price Chart

C$0.07+C$0.00 (+0.00%)today

−56.25%CAGR −15.26%

Select date range

FromTo

Dec 1, 1999Aug 28, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

MIR.V does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateJun 30

Last Report DateJun 30

Reported vs Estimate−C$0.00

Earnings Surprise—

FinancialsFinancials Tab

RevenueC$370.57K

Net Income−C$2.99M

Net Margin−808.2%

Operating Cash Flow−C$1.19M

Capital ExpendituresC$0.00

Free Cash Flow−C$1.19M

Return on Equity—

Return on Invested Capital3.7%

Net DebtC$17.42M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for MIR.V and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how MIR.V's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for MIR.V and 80,000+ other tickers.

About MedMira Inc.

MedMira Inc. is a biotechnology company focused on the research, development, manufacturing, and global commercialization of rapid diagnostic solutions and related technology platforms. Its operations span North America, Europe, the Asia Pacific region, and other international markets. MedMira offers a diverse portfolio of rapid diagnostic tests and technology platforms. Its diagnostic solutions include Reveal HIV, which identifies HIV-1 and HIV-2 antibodies in various blood samples; Reveal TP, a rapid test for syphilis antibodies (Treponema pallidum); and Reveal HP, designed to detect…

CEO: Hermes Chan
Sector: Healthcare
Industry: Biotechnology
Exchange: TSXV
Employees: 52
Website: www.medmira.com

Peers

Defence Therapeutics Inc.

Cap

C$38.7M

TLT.V

Theralase Technologies Inc.

Cap

C$53.2M

Latest News

News Tab

No recent news available.

Frequently Asked Questions About MIR.V

What does MedMira Inc. do?: MedMira Inc. (MIR.V) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is MIR.V's market cap?: MedMira Inc. (MIR.V) has a market capitalization of approximately $49.1 million, as of August 27, 2026, based on the most recent share price and shares outstanding.
Does MIR.V pay a dividend?: No — MedMira Inc. (MIR.V) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is MIR.V profitable?: MedMira Inc. (MIR.V) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.